Cochrane Abstracts
Oral budesonide for induction of remission in ulcerative colitis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral Budesonide for Induction of Remission in Ulcerative Colitis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435309/all/Tocilizumab_for_rheumatoid_arthritis:_Cochrane_systematic_review. Accessed 21 September 2023.
Oral budesonide for induction of remission in ulcerative colitis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435309/all/Tocilizumab_for_rheumatoid_arthritis:_Cochrane_systematic_review. Accessed September 21, 2023.
Oral budesonide for induction of remission in ulcerative colitis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435309/all/Tocilizumab_for_rheumatoid_arthritis:_Cochrane_systematic_review
Oral Budesonide for Induction of Remission in Ulcerative Colitis [Internet]. In: Cochrane Abstracts. [cited 2023 September 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435309/all/Tocilizumab_for_rheumatoid_arthritis:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral budesonide for induction of remission in ulcerative colitis
ID - 435309
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435309/all/Tocilizumab_for_rheumatoid_arthritis:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
